Industry Overview
In a world where chronic wounds linger, threatening lives and well-being, Palm Beach Biologix offers products to help clinicians all over the country emerge as a beacon of hope, armed with a commitment to transformative wound care.
Contact Us
Wound Care Sector
According to the National Library of Medicine, the United States spent $126.9 Billion in the year 2019 on chronic wounds.
A Costly Disease
According to The Journal of Foot and Ankle Research, Diabetic Foot Disease alone costs America about $80 Billion per year in both direct and indirect costs. This is almost the same amount as what was spent on cancer in 2015.
Demand for Advanced Healing Products
According to MDPI, a non-profit association that publishes open-access scientific journals, there are approximately 37.3 Million adult Americans with diabetes, and it is projected that each year this number will grow by 1.4 Million adult Americans diagnosed with diabetes mellitus. Many diabetic foot ulcers (DFUs) have a high recurrence rate, with 65% of the ulcers returning within five years. The inability to heal DFUs presents a severe danger to patients, as anywhere from 5 to 24% of untreated DFUs can lead to limb amputation within 6-18 months. These infections can lead to long-term impairment and possible lower-limb amputation without timely and correct management. The inability to heal these DFUs presents a severe danger to the healthcare system in our country. Therefore, advancing knowledge and care for this disease and its related conditions is especially relevant.
Advancing Biologic Therapies
Palm Beach Biologix (PBB) is one of North America’s premier FDA-licensed tissue banks that offers regenerative solution products to improve health outcomes.
PBB has grown its business and brand equity by building enduring, strategic relationships with its key Providers across the country, and by delivering innovative, category-best products and value.
PBB is redefining the status quo of the wound care industry, which will continue its growth in market share over the course of the next decade.
